Skip to main content

Table 1 Patient demographics and clinical characteristics (n = 63)

From: Risk factors for venous irritation in patients receiving vinorelbine: a retrospective study

Variable

Value

Median age, years (range)

65.0 (35–84)

Sex, male/female

41/22

Median body height, cm (range)

163.8 (144.9–180.9)

Median body weight, kg (range)

59.4 (39.6–80.5)

Median body surface area, m2 (range)

1.67 (1.27–1.92)

Median body mass index, kg/m2 (range)

22.3 (16.7–29.3)

Chemotherapeutic regimen, (n)

 VNR alone

12

 VNR + CDDP

45

 VNR + HER

5

 VNR + GEM

1

Department

 Respiratory medicine

26

 Thoracic surgery

26

 Breast surgery

11

Median VNR dose, mg/body (range)

37 (29–47)

Median total cycles, n (range)

4 (1–16)

Administration, main route/side port

19/44

Drug formulation, branded/generic

52/11

History of diabetes mellitus, yes/no

10/53

Dose of dexamethasone used for premedication 13.2/9.9/6.6 mg

38/6/19

Hot compress with hot towel, yes/no

14/49

  1. VNR vinorelbine, CDDP cisplatin, HER trastuzumab, GEM gemcitabine